- $20.36m
- $19.93m
- $8.69m
- 16
- 30
- 56
- 25
Annual income statement for Nexgel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.674 | 1.55 | 2.05 | 4.09 | 8.69 |
| Cost of Revenue | |||||
| Gross Profit | -0.291 | 0.009 | 0.256 | 0.619 | 2.75 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.93 | 3.87 | 5.55 | 7.57 | 12.2 |
| Operating Profit | -2.26 | -2.32 | -3.5 | -3.48 | -3.55 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.26 | -4.31 | -4.75 | -3.19 | -3.46 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.26 | -4.31 | -4.75 | -3.19 | -3.46 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.26 | -4.31 | -4.75 | -3.16 | -3.28 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.26 | -4.31 | -4.75 | -3.16 | -3.28 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.407 | -0.818 | -0.824 | -0.557 | -0.504 |